The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.
CHPA announced its strong support for the Restoring Access to Medicines Act of 2015 (H.R. 1270).
The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.
The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.
ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.
Congress introdues legislation to protect FDA user fees from sequestration.
The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.
Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo.
The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration.
The National Association of Chain Drug Stores has submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health expressing concerns about pharmacy-related budget proposals.